-
Je něco špatně v tomto záznamu ?
Large differencies in age-specific survival in multiple myeloma in the nordic countries
K. Hemminki, F. Zitricky, A. Försti, R. Silvennoinen, A. Vangsted, M. Hansson
Jazyk angličtina Země Spojené státy americké
Typ dokumentu dopisy
Grantová podpora
856620
EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Freely Accessible Science Journals
od 2011-01-28
Nature Open Access
od 2011-01-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- MeSH
- lidé MeSH
- mnohočetný myelom * epidemiologie terapie MeSH
- rizikové faktory MeSH
- věkové faktory MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- Geografické názvy
- Skandinávie a severské státy MeSH
Department of Hematology Rigshospitalet Copenhagen Denmark
Division of Pediatric Neurooncology German Cancer Research Center Heidelberg Germany
Hematology and Transfusion Medicine Department of Laboratory Medicine BMC B13 221 84 Lund Sweden
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24006747
- 003
- CZ-PrNML
- 005
- 20240423155458.0
- 007
- ta
- 008
- 240412s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41408-024-01026-6 $2 doi
- 035 __
- $a (PubMed)38467614
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hemminki, Kari $u Biomedical Center, Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605, Pilsen, Czech Republic. K.Hemminki@dkfz.de $u Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany. K.Hemminki@dkfz.de $1 https://orcid.org/0000000227693316 $7 mzk20201092711
- 245 10
- $a Large differencies in age-specific survival in multiple myeloma in the nordic countries / $c K. Hemminki, F. Zitricky, A. Försti, R. Silvennoinen, A. Vangsted, M. Hansson
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mnohočetný myelom $x epidemiologie $x terapie $7 D009101
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a věkové faktory $7 D000367
- 651 _2
- $a Skandinávie a severské státy $x epidemiologie $7 D012537
- 655 _2
- $a dopisy $7 D016422
- 700 1_
- $a Zitricky, Frantisek $u Biomedical Center, Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605, Pilsen, Czech Republic
- 700 1_
- $a Försti, Asta $u Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany
- 700 1_
- $a Silvennoinen, Raija $u Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, & University of Helsinki, Helsinki, Finland $1 https://orcid.org/0000000189391586
- 700 1_
- $a Vangsted, Annette $u Department of Hematology, Rigshospitalet, Copenhagen, Denmark $1 https://orcid.org/000000022131731X
- 700 1_
- $a Hansson, Markus $u Department of Internal Medicine and Clinical Nutrition, Sahlgrenska University Hospital/Sahlgrenska Academy, Bruna stråket 5 plan 5, 41325, Göteborg, Sweden $u Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden
- 773 0_
- $w MED00187996 $t Blood cancer journal $x 2044-5385 $g Roč. 14, č. 1 (2024), s. 43
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38467614 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155454 $b ABA008
- 999 __
- $a ok $b bmc $g 2081001 $s 1216514
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 14 $c 1 $d 43 $e 20240311 $i 2044-5385 $m Blood cancer journal $n Blood Cancer J $x MED00187996
- GRA __
- $a 856620 $p EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
- LZP __
- $a Pubmed-20240412